PharmaResources Valuation
| 301230 Stock | 27.35 0.35 1.30% |
At this time, the company appears to be overvalued. PharmaResources holds a recent Real Value of USD21.19 per share. The prevailing price of the company is USD27.35. Our model determines the value of PharmaResources from analyzing the company fundamentals such as Shares Outstanding of 139.59 M, operating margin of (0.05) %, and Return On Equity of 0.0064 as well as examining its technical indicators and probability of bankruptcy.
Price Book 3.6081 | Enterprise Value 3.6 B | Enterprise Value Ebitda 946.8242 | Price Sales 7.4288 | Enterprise Value Revenue 6.995 |
Overvalued
Today
Please note that PharmaResources' price fluctuation is somewhat reliable at this time. Calculation of the real value of PharmaResources is based on 3 months time horizon. Increasing PharmaResources' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since PharmaResources is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PharmaResources Stock. However, PharmaResources' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.35 | Real 21.19 | Hype 27.18 |
The real value of PharmaResources Stock, also known as its intrinsic value, is the underlying worth of PharmaResources Company, which is reflected in its stock price. It is based on PharmaResources' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PharmaResources' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PharmaResources Co Ltd helps investors to forecast how PharmaResources stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PharmaResources more accurately as focusing exclusively on PharmaResources' fundamentals will not take into account other important factors: PharmaResources Total Value Analysis
PharmaResources Co Ltd is presently forecasted to have takeover price of 3.59 B with market capitalization of 3.82 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the PharmaResources fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.59 B | 3.82 B |
PharmaResources Asset Utilization
One of the ways to look at asset utilization of PharmaResources is to check how much profit was generated for every dollar of assets it reports. PharmaResources holds a negative application of assets of -0.0102 pct., losing USD1.02E-4 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of PharmaResources Co Ltd shows how discouraging it operates for each dollar spent on its assets.PharmaResources Ownership Allocation
PharmaResources owns a total of 139.59 Million outstanding shares. PharmaResources has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PharmaResources' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PharmaResources and how it compares across the competition.
About PharmaResources Valuation
The stock valuation mechanism determines PharmaResources' current worth on a weekly basis. Our valuation model uses a comparative analysis of PharmaResources. We calculate exposure to PharmaResources's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PharmaResources's related companies.Complementary Tools for PharmaResources Stock analysis
When running PharmaResources' price analysis, check to measure PharmaResources' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaResources is operating at the current time. Most of PharmaResources' value examination focuses on studying past and present price action to predict the probability of PharmaResources' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaResources' price. Additionally, you may evaluate how the addition of PharmaResources to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |